Market Overview

UPDATE: Morgan Stanley Downgrades Baker Hughes on Outperformance

Share:
Related BHI
OPEC Expects Less From Competition In 2016
Report: Halliburton Plans On Selling Baker Hughes' Offshore Fluids Unit
Unusual Option Activity Briefing: A Very Bullish Bet On ZIOPHARM (Seeking Alpha)

In an report published Tuesday morning, Morgan Stanley analyst Ole Slorer downgrades Baker Hughes (NYSE: BHI) from Overweight to Equal-weight, lowering price target from $66 to $62.

The report states that BHI will unlikely outperform its peers until they reduce costs to close their margin gap. It is unlikely to follow through with this without an environment that will foster rapid growth. Ole notes, "Market share continues to modestly erode, growing 100bps slower than peers."

BHI closed previously on Monday at $52.55 and currently trading at $53.

Latest Ratings for BHI

DateFirmActionFromTo
Feb 2016Morgan StanleyDowngradesOverweightEqual-weight
Jan 2016Deutsche BankMaintainsBuy
Jan 2016KeyBancUpgradesSector WeightOverweight

View More Analyst Ratings for BHI
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ole SlorerAnalyst Color Downgrades Analyst Ratings

 

Related Articles (BHI)

View Comments and Join the Discussion!

Get Benzinga's Newsletters